Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

Matteo G. Della Porta, Emilio Paolo Alessandrino, Andrea Bacigalupo, Maria Teresa Van Lint, Luca Malcovati, Cristiana Pascutto, Michele Falda, Massimo Bernardi, Francesco Onida, Stefano Guidi, Anna Paola Iori, Raffaella Cerretti, Paola Marenco, Pietro Pioltelli, Emanuele Angelucci, Rosi Oneto, Francesco Ripamonti, Paolo Bernasconi, Alberto Bosi, Mario CazzolaAlessandro Rambaldi

Research output: Contribution to journal › Article

94 Citations (Scopus)

Abstract

Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,

Original languageEnglish
Pages (from-to)2333-2342
Number of pages10
JournalBlood
Volume123
Issue number15
DOIs
Publication statusPublished - Apr 10 2014

Fingerprint

Transplants
Myelodysplastic Syndromes
Homologous Transplantation
Stem cells
Hematopoietic Stem Cell Transplantation
Treatment Failure
Acute Myeloid Leukemia
Transplantation
Recurrence
allogenic effect factor
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Biochemistry
  • Cell Biology
  • Immunology

Cite this

Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. / Della Porta, Matteo G.; Alessandrino, Emilio Paolo; Bacigalupo, Andrea; Van Lint, Maria Teresa; Malcovati, Luca; Pascutto, Cristiana; Falda, Michele; Bernardi, Massimo; Onida, Francesco; Guidi, Stefano; Iori, Anna Paola; Cerretti, Raffaella; Marenco, Paola; Pioltelli, Pietro; Angelucci, Emanuele; Oneto, Rosi; Ripamonti, Francesco; Bernasconi, Paolo; Bosi, Alberto; Cazzola, Mario; Rambaldi, Alessandro.

In: Blood, Vol. 123, No. 15, 10.04.2014, p. 2333-2342.

Research output: Contribution to journal › Article

Della Porta, MG, Alessandrino, EP, Bacigalupo, A, Van Lint, MT, Malcovati, L, Pascutto, C, Falda, M, Bernardi, M, Onida, F, Guidi, S, Iori, AP, Cerretti, R, Marenco, P, Pioltelli, P, Angelucci, E, Oneto, R, Ripamonti, F, Bernasconi, P, Bosi, A, Cazzola, M & Rambaldi, A 2014, 'Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R', Blood, vol. 123, no. 15, pp. 2333-2342. https://doi.org/10.1182/blood-2013-12-542720
Della Porta MG, Alessandrino EP, Bacigalupo A, Van Lint MT, Malcovati L, Pascutto C et al. Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. Blood. 2014 Apr 10;123(15):2333-2342. https://doi.org/10.1182/blood-2013-12-542720
Della Porta, Matteo G. ; Alessandrino, Emilio Paolo ; Bacigalupo, Andrea ; Van Lint, Maria Teresa ; Malcovati, Luca ; Pascutto, Cristiana ; Falda, Michele ; Bernardi, Massimo ; Onida, Francesco ; Guidi, Stefano ; Iori, Anna Paola ; Cerretti, Raffaella ; Marenco, Paola ; Pioltelli, Pietro ; Angelucci, Emanuele ; Oneto, Rosi ; Ripamonti, Francesco ; Bernasconi, Paolo ; Bosi, Alberto ; Cazzola, Mario ; Rambaldi, Alessandro. / Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R. In: Blood. 2014 ; Vol. 123, No. 15. pp. 2333-2342.
@article{b33c8dd4507d479fb0fa737749606354,
title = "Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R",
abstract = "Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,",
author = "{Della Porta}, {Matteo G.} and Alessandrino, {Emilio Paolo} and Andrea Bacigalupo and {Van Lint}, {Maria Teresa} and Luca Malcovati and Cristiana Pascutto and Michele Falda and Massimo Bernardi and Francesco Onida and Stefano Guidi and Iori, {Anna Paola} and Raffaella Cerretti and Paola Marenco and Pietro Pioltelli and Emanuele Angelucci and Rosi Oneto and Francesco Ripamonti and Paolo Bernasconi and Alberto Bosi and Mario Cazzola and Alessandro Rambaldi",
year = "2014",
month = "4",
day = "10",
doi = "10.1182/blood-2013-12-542720",
language = "English",
volume = "123",
pages = "2333--2342",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "15",

}

TY - JOUR

T1 - Predictive factors for the outcome of allogeneic transplantation in patients with MDS stratified according to the revised IPSS-R

AU - Della Porta, Matteo G.

AU - Alessandrino, Emilio Paolo

AU - Bacigalupo, Andrea

AU - Van Lint, Maria Teresa

AU - Malcovati, Luca

AU - Pascutto, Cristiana

AU - Falda, Michele

AU - Bernardi, Massimo

AU - Onida, Francesco

AU - Guidi, Stefano

AU - Iori, Anna Paola

AU - Cerretti, Raffaella

AU - Marenco, Paola

AU - Pioltelli, Pietro

AU - Angelucci, Emanuele

AU - Oneto, Rosi

AU - Ripamonti, Francesco

AU - Bernasconi, Paolo

AU - Bosi, Alberto

AU - Cazzola, Mario

AU - Rambaldi, Alessandro

PY - 2014/4/10

Y1 - 2014/4/10

N2 - Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,

AB - Approximately one-third of patients with myelodysplastic syndrome (MDS) receiving allogeneic hematopoietic stem cell transplantation (HSCT) are cured by this treatment. Treatment failure maybe due to transplant complications or relapse. To identify predictive factors for transplantation outcome, we studied 519 patients with MDS or oligoblastic acute myeloid leukemia (AML,

UR - http://www.scopus.com/inward/record.url?scp=84901701732&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901701732&partnerID=8YFLogxK

U2 - 10.1182/blood-2013-12-542720

DO - 10.1182/blood-2013-12-542720

M3 - Article

C2 - 24558201

AN - SCOPUS:84901701732

VL - 123

SP - 2333

EP - 2342

JO - Blood

JF - Blood

SN - 0006-4971

IS - 15

ER -

Access to Document